Stay updated with breaking news from Replicate Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, autoimmune disease, and more, today announced acceptance of two oral presentations at the upcoming...
Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making. Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making.
/PRNewswire/ -- The "Global Lipid Nanoparticles Market Analysis & Forecast 2024-2034: Market By Type; By Application; By End-user; and By Region" report has...
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA) GlobeNewswire September 13, 2023 ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today...
The tech has lots of applications beyond the one we've already been injected with.